Health Canada updated its core Good Pharmacovigilance Practices framework in 2026. The current guidance distinguishes legislation from administrative guidance and explains Health Canada's interpretation of post-market pharmacovigilance requirements.
Core official resources
- Good pharmacovigilance practices guidelines (GUI-0102) — current GVP guidance for manufacturers and market authorisation holders.
- GUI-0102: The regulations — presents relevant regulatory text together with rationale and Health Canada interpretation.
- Good pharmacovigilance practices inspection approach policy (POL-0041) — current inspection policy.
- Good pharmacovigilance practices inspections — inspection information and links to the GVP inspection database.
Practical use
GUI-0102 is especially useful because it clearly separates the regulatory provisions from Health Canada's explanatory interpretation. For operational decisions, verify the underlying Food and Drug Regulations as well as the current guidance.